181 related articles for article (PubMed ID: 2370014)
1. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.
Brynskov J; Tvede N
Gut; 1990 Jul; 31(7):795-9. PubMed ID: 2370014
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.
Crabtree JE; Juby LD; Heatley RV; Lobo AJ; Bullimore DW; Axon AT
Gut; 1990 Sep; 31(9):1033-6. PubMed ID: 2210449
[TBL] [Abstract][Full Text] [Related]
3. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
[TBL] [Abstract][Full Text] [Related]
4. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy.
Simsek H; Kadayifci A
J Int Med Res; 1996; 24(3):239-45. PubMed ID: 8725984
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.
Schürmann G; Betzler M; Post S; Herfarth C; Meuer S
Digestion; 1992; 51(1):51-9. PubMed ID: 1639222
[TBL] [Abstract][Full Text] [Related]
7. Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission.
Van Kemseke C; Belaiche J; Louis E
Int J Colorectal Dis; 2000 Aug; 15(4):206-10. PubMed ID: 11008719
[TBL] [Abstract][Full Text] [Related]
8. Clinical response to cyclosporin in chronic severe asthma is associated with reduction in serum soluble interleukin-2 receptor concentrations.
Alexander AG; Barnes NC; Kay AB; Corrigan CJ
Eur Respir J; 1995 Apr; 8(4):574-8. PubMed ID: 7664856
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.
Mitsuyama K; Toyonaga A; Sasaki E; Ishida O; Ikeda H; Tsuruta O; Harada K; Tateishi H; Nishiyama T; Tanikawa K
Gut; 1995 Jan; 36(1):45-9. PubMed ID: 7890234
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
Srivastava MD; Rossi TM; Lebenthal E
Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
[TBL] [Abstract][Full Text] [Related]
11. The circulating common gamma chain (CD132) in inflammatory bowel disease.
Nielsen OH; Kirman I; Johnson K; Giedlin M; Ciardelli T
Am J Gastroenterol; 1998 Mar; 93(3):323-8. PubMed ID: 9517632
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-2 receptor and disease activity in Crohn's disease.
Williams AJ; Symons JA; Watchet K; Duff GW
J Autoimmun; 1992 Apr; 5(2):251-9. PubMed ID: 1627235
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-2 receptor as a marker of lymphocyte activation in childhood Crohn's disease.
Proujansky R; Carpenter AB
J Pediatr Gastroenterol Nutr; 1991 Oct; 13(3):277-84. PubMed ID: 1791504
[TBL] [Abstract][Full Text] [Related]
14. [Serum IL-2 and sIL-2R concentration in children with chronic hepatitis B].
Pawłowska M; Halota W; Smukalska E; Grabczewska E
Pol Merkur Lekarski; 2005 Jan; 18(103):33-5. PubMed ID: 15859543
[TBL] [Abstract][Full Text] [Related]
15. [Changes of serum interleukin 2 and soluble interleukin 2 receptor and their clinical significance in multiple myeloma].
Wang Z; Li D; Yang J
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):439-41. PubMed ID: 9387297
[TBL] [Abstract][Full Text] [Related]
16. High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma.
Wang L; Wang JH; Liu WJ; Wang WD; Wang H; Chen XQ; Geng QR; Lu Y; Xia ZJ
Ann Hematol; 2017 Dec; 96(12):2079-2088. PubMed ID: 28871325
[TBL] [Abstract][Full Text] [Related]
17. The levels of plasma interleukin-2 and soluble interleukin-2R in Behçet's disease: a marker of disease activity.
Alpsoy E; Cayirli C; Er H; Yilmaz E
J Dermatol; 1998 Aug; 25(8):513-6. PubMed ID: 9769596
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between the serum levels of interleukin-2 and soluble interleukin-2 receptor and the response to immunosuppressive therapy in severe aplastic anemia patients].
Shao Z; Chen K; Chen G; Zhang Y; Wang T; Zou R; Zhou X; Zhou Y; Chu Y
Zhonghua Xue Ye Xue Za Zhi; 1997 Apr; 18(4):180-2. PubMed ID: 15622762
[TBL] [Abstract][Full Text] [Related]
19. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-6, soluble interleukin-6 receptor and Crohn's disease activity.
Nancey S; Hamzaoui N; Moussata D; Graber I; Bienvenu J; Flourie B
Dig Dis Sci; 2008 Jan; 53(1):242-7. PubMed ID: 17549633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
